A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia.

Trial Profile

A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Jul 2017

At a glance

  • Drugs Esomeprazole (Primary) ; Aspirin
  • Indications Barrett's oesophagus; Oesophageal cancer
  • Focus Therapeutic Use
  • Acronyms AspECT
  • Most Recent Events

    • 11 Feb 2015 New source identified and integrated ISRCTN:Current Controlled Trials (ISRCTN85156844)
    • 01 Dec 2014 Planned End Date changed from 1 Mar 2019 to 1 May 2017, according to ClinicalTrials.gov record.
    • 01 Dec 2014 Planned primary completion date changed from 1 Mar 2019 to 1 May 2017, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top